IDEXX Laboratories (IDXX) Earnings Date, Estimates & Call Transcripts $417.24 -1.31 (-0.31%) (As of 11/22/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends IDEXX Laboratories Latest Earnings SummaryUpcoming Q4 Earnings DateFeb. 3EstimatedActual EPS (Oct. 31) $2.80 Beat By $0.11 Consensus EPS (Oct. 31) $2.69 IDEXX Laboratories issued Q3 2024 earnings on October 31, 2024, reporting an EPS of $2.80, which beat the consensus estimate of $2.69 by $0.11. Quarterly revenue rose 6.6% year-over-year to $975.50 million, below analysts' expectations of $980.32 million. With a trailing EPS of $10.37 and a P/E Ratio of 40.24, IDEXX Laboratories' earnings are expected to grow 15.34% next year, from $10.43 to $12.03 per share. Conference Call TranscriptConference Call AudioEarnings Press ReleaseEarnings Slide DeckSEC 10-Q/10-K FilingIDXX Upcoming EarningsIDEXX Laboratories' next earnings date is estimated for Monday, February 3, 2025, based off prior year's reporting schedules. Get IDEXX Laboratories Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on IDEXX Laboratories and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataIDXX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.IDXX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Porter & CompanyWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. IDEXX Laboratories Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20242$2.55$2.72$2.64 Q2 20242$2.84$2.86$2.85 Q3 20242$2.69$2.78$2.74 Q4 20242$2.62$2.91$2.77 FY 20248$10.70$11.27$10.99 Q1 20252$2.96$3.08$3.02 Q2 20252$3.00$3.19$3.10 Q3 20252$3.13$3.15$3.14 Q4 20251$3.16$3.16$3.16 FY 20257$12.25$12.58$12.42 Q1 20261$3.55$3.55$3.55 Q3 20261$3.51$3.51$3.51 IDEXX Laboratories Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 2/3/2025(Estimated)------- 10/31/2024Q3 2024$2.69$2.80+$0.11$2.80$980.32M$975.50M 8/6/2024Q2 2024$2.88$2.44 -$0.44$2.44$1.01B$1.00B 5/1/2024Q1 2024$2.68$2.81+$0.13$2.81$965.43M$964.10M 2/5/2024Q4 2023$2.12$2.32+$0.20$2.32$891.88M$901.60M 11/1/2023Q3 2023$2.37$2.53+$0.16$2.53$926.88M$915.53M 8/1/2023Q2 2023$2.43$2.67+$0.24$2.67$927.84M$943.63M Get the Latest News and Ratings for IDXX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for IDEXX Laboratories and its competitors with MarketBeat's FREE daily newsletter. 5/2/2023Q1 2023$2.38$2.55+$0.17$2.55$887.36M$900.20M 2/6/2023Q4 2022$1.92$2.05+$0.13$2.05$820.91M$828.60M IDEXX Laboratories Earnings - Frequently Asked Questions When is IDEXX Laboratories's earnings date? IDEXX Laboratories has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 3rd, 2025 based off last year's report dates. Learn more on IDXX's earnings history. What guidance has IDEXX Laboratories issued on next quarter's earnings? IDEXX Laboratories issued an update on its FY24 earnings guidance on Thursday, November, 21st. The company provided earnings per share (EPS) guidance of $10.37-10.53 for the period, compared to the consensus estimate of $10.45. The company issued revenue guidance of $3.87-3.89 billion, compared to the consensus revenue estimate of $3.88 billion. Did IDEXX Laboratories beat their earnings estimates last quarter? In the previous quarter, IDEXX Laboratories (NASDAQ:IDXX) reported $2.80 earnings per share (EPS) to beat the analysts' consensus estimate of $2.69 by $0.11. Learn more on analysts' earnings estimate vs. IDXX's actual earnings. How can I listen to IDEXX Laboratories's earnings conference call? The conference call for IDEXX Laboratories's latest earnings report can be listened to online. Listen to Conference Call How can I read IDEXX Laboratories's conference call transcript? The conference call transcript for IDEXX Laboratories's latest earnings report can be read online. Read Transcript How can I view IDEXX Laboratories's earnings report? IDEXX Laboratories's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does IDEXX Laboratories generate each year? IDEXX Laboratories (NASDAQ:IDXX) has a recorded annual revenue of $3.66 billion. How much profit does IDEXX Laboratories generate each year? IDEXX Laboratories (NASDAQ:IDXX) has a recorded net income of $845.04 million. IDXX has generated $10.37 earnings per share over the last four quarters. What is IDEXX Laboratories's price-to-earnings ratio? IDEXX Laboratories (NASDAQ:IDXX) has a trailing price-to-earnings ratio of 40.24 and a forward price-to-earnings ratio of 40.00. The price/earnings-to-growth ratio is 3.65. What is IDEXX Laboratories's EPS forecast for next year? IDEXX Laboratories's earnings are expected to grow from $10.43 per share to $12.03 per share in the next year, which is a 15.34% increase. ` More Earnings Resources from MarketBeat Related Companies Boston Scientific Earnings Date Medtronic Earnings Date Becton, Dickinson and Company Earnings Date Edwards Lifesciences Earnings Date ResMed Earnings Date DexCom Earnings Date STERIS Earnings Date Insulet Earnings Date Hologic Earnings Date Baxter International Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report War on Elon Escalates… (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. This page (NASDAQ:IDXX) was last updated on 11/24/2024 by MarketBeat.com Staff From Our Partners[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | Sponsored#1 Crypto of 2024Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IDEXX Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IDEXX Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
